In March 2025, the company declared new programs for a direct-to-customer providing of its Wegovy weight loss drug. The company recognized a different pharmacy, known as NovoCare, which would charge buyers $499 a month for usage of the drug, below half the expense of the drug via other pharmaceutical distribution networks.[fifty three]Novo Nordisk